Skip to main content

Table 7 Recommendations for CMR in patients with HCM

From: Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology

Recommendations for CMR in patients with HCM Classa Levelb Page
It is recommended that CMR studies be performed and interpreted by teams experienced in cardiac imaging and in the evaluation of heart muscle disease I B 14
In the absence of contraindications, CMR with LGE is recommended in patients with suspected HCM who have inadequate echocardiographic windows, in order to confirm the diagnosis. I C 14
In the absence of contraindications, CMR with LGE should be considered in patients fulfilling diagnostic criteria for HCM, to assess cardiac anatomy, ventricular function, and the presence and extent of myocardial fibrosis. IIa B 14
CMR with LGE imaging should be considered in patients with suspected apical hypertrophy or aneurysm. IIa C 14
CMR with LGE imaging should be considered in patients with suspected cardiac amyloidosis. IIa C 14
CMR with LGE may be considered before septal alcohol ablation or myectomy, to assess the extent and distribution of hypertrophy and myocardial fibrosis. IIb C 14
CMR may be considered every 5 years in clinically stable patients, or every 2–3 years in patients with progressive disease. IIb C 37
  1. a Class of recommendation
  2. b Level of evidence